Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
CSL ( (AU:CSL) ) has issued an announcement.
CSL Limited announced the lapse of 19,884 conditional rights to securities, effective January 10, 2025, due to certain conditions not being met. This cessation of securities may impact the company’s capital management strategies and could influence stakeholder perceptions regarding the company’s financial maneuvers.
More about CSL
CSL Limited operates in the biotechnology industry and specializes in the development and delivery of innovative medicines and therapies. The company focuses on providing solutions in areas such as immunology, hematology, and respiratory care.
YTD Price Performance: 0.14%
Average Trading Volume: 563
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $84.81B
See more data about CSL stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue